EA201200889A1 - Пептид - Google Patents

Пептид

Info

Publication number
EA201200889A1
EA201200889A1 EA201200889A EA201200889A EA201200889A1 EA 201200889 A1 EA201200889 A1 EA 201200889A1 EA 201200889 A EA201200889 A EA 201200889A EA 201200889 A EA201200889 A EA 201200889A EA 201200889 A1 EA201200889 A1 EA 201200889A1
Authority
EA
Eurasian Patent Office
Prior art keywords
immunomodulate
peptides
peptide
food compositions
new peptides
Prior art date
Application number
EA201200889A
Other languages
English (en)
Other versions
EA022214B1 (ru
Inventor
Ганеш Чандрамоули
Бабу Ракеш Кумар Банди
Original Assignee
Юнилевер Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнилевер Н.В. filed Critical Юнилевер Н.В.
Publication of EA201200889A1 publication Critical patent/EA201200889A1/ru
Publication of EA022214B1 publication Critical patent/EA022214B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Настоящее изобретение относится к новым пептидам и к композициям для местного нанесения и пищевым композициям, содержащим эти пептиды. Новые пептиды применяют для осветления кожи и иммуномодуляции при местном нанесении и для иммуномодуляции и модуляции массы тела при использовании в пищевых композициях.
EA201200889A 2009-12-16 2010-11-23 Пептид EA022214B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2898MU2009 2009-12-16
PCT/EP2010/067972 WO2011072991A1 (en) 2009-12-16 2010-11-23 Peptide

Publications (2)

Publication Number Publication Date
EA201200889A1 true EA201200889A1 (ru) 2013-01-30
EA022214B1 EA022214B1 (ru) 2015-11-30

Family

ID=43533119

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201200889A EA022214B1 (ru) 2009-12-16 2010-11-23 Пептид

Country Status (11)

Country Link
US (1) US8580920B2 (ru)
EP (1) EP2512496B1 (ru)
JP (1) JP5752145B2 (ru)
CN (1) CN103313723B (ru)
BR (1) BR112012013095A2 (ru)
CA (1) CA2782131C (ru)
EA (1) EA022214B1 (ru)
ES (1) ES2541364T3 (ru)
MX (1) MX2012007034A (ru)
WO (1) WO2011072991A1 (ru)
ZA (1) ZA201203722B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105916487B (zh) * 2013-10-18 2020-03-24 米尼翁大学 肽组合物及其用途
US11712410B2 (en) 2018-09-05 2023-08-01 K18, Inc. Composition for improving hair health
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389950A1 (en) * 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
GB9719195D0 (en) * 1997-09-09 1997-11-12 Unilever Plc Skin lightening composition
WO2001088088A2 (en) * 2000-05-18 2001-11-22 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2001002527A (ja) 1999-06-22 2001-01-09 Lion Corp 皮膚外用剤組成物
US20070060743A1 (en) * 2001-05-16 2007-03-15 Tang Y Tom Novel nucleic acids and polypeptides
EP1615991A4 (en) 2003-04-03 2007-12-19 Bristol Myers Squibb Co POLYNUCLEOTIDE ENCODING A NEW HUMAN P2X7 SPLICE VARIANT CALLED HBMYP2X7V
EP2090662A3 (en) 2006-04-05 2012-10-31 Metanomics GmbH Process for the production of a fine chemical
FR2900573B1 (fr) * 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema

Also Published As

Publication number Publication date
WO2011072991A1 (en) 2011-06-23
CN103313723A (zh) 2013-09-18
CA2782131C (en) 2018-12-11
EA022214B1 (ru) 2015-11-30
ZA201203722B (en) 2013-08-28
CN103313723B (zh) 2015-02-04
US8580920B2 (en) 2013-11-12
US20120263665A1 (en) 2012-10-18
EP2512496A1 (en) 2012-10-24
BR112012013095A2 (pt) 2017-05-16
EP2512496B1 (en) 2015-04-01
JP2013514291A (ja) 2013-04-25
ES2541364T3 (es) 2015-07-17
MX2012007034A (es) 2012-07-04
CA2782131A1 (en) 2011-06-23
JP5752145B2 (ja) 2015-07-22

Similar Documents

Publication Publication Date Title
BR112013032717A2 (pt) coagonistas do receptor de glucagon/glp-1
UA112416C2 (uk) Антитіло до fap і способи його застосування
EA201001223A1 (ru) Стабилизированные белковые композиции
MX2016007063A (es) Peptidos terapeuticos.
UA118167C2 (uk) Пептид та його застосування
WO2012143364A3 (en) Cosmetic composition for use in increasing collagen synthesis in skin cells
EA201390254A1 (ru) Модифицированные полипептиды релаксина и их применение
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
EA201171494A1 (ru) Миметики белка smac
CL2016000344A1 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
TW201129377A (en) Binding proteins that bind to human FGFR1c, human β-Klotho and both human FGFR1c and human β-Klotho
CL2011000086A1 (es) Anticuerpo aislado o proteina funcional contra el polipeptido baffr que inhibe la proliferacion de celulas b; secuencia nucleotidicas de dicho anticuerpo; vector y celula huesped que comprende dicha secuencia; y su uso para tratar enfermedades autoinmunes o neoplasias de celulas b.
EA201270722A1 (ru) Формы рифаксимина и их применение
EA201370018A1 (ru) Составы рифаксимина и их применение
EA201291180A1 (ru) Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
CU24405B1 (es) Proteínas de variantes de secuencias de aminoácidos de cry1da1 activas para lepidópteros
EA201101214A1 (ru) Полиеновые противогрибковые композиции
EA201201623A1 (ru) Лечение диабета 2 типа
HK1142828A1 (en) Hydrolysable polymeric fmoc-linker
EA201290542A1 (ru) Модифицированные свиные соматотропиновые полипептиды и их применение
WO2011100688A8 (en) Improved antagonists of muc1
EA201390955A1 (ru) Слитый белок robo1-fc для применения в лечении гепатокарциномы
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
WO2011126940A3 (en) Topical uses of szeto-schiller peptides
MX345695B (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment